The Latest Cardiac and Vascular News
The application includes data from the STTAR clinical study with a one-year follow-up period. NEWTOWN, Pa. Jan. 29, 2021 / PRNewswire / – Micro Interventional Devices, Inc. ™ (MID) announced today that it has provided the technical documentation required for CE approval of its MIA-T ™ Percutaneous Tricuspid Annuloplasty System for tricuspid valve […]
NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on its pipeline of late-stage product candidates, and an activity report for the second quarter ended December 31, 2020. Mesoblast Chief Executive Dr Silviu Itescu […]
SAN FRANCISCO, Jan. 29, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recent publication by Novitas Solutions (“Novitas”) of rates applicable to the Current Procedural Terminology (CPT) codes 93241, 93243, 93245 and […]
Positive opinion is based on extensive clinical study results, including results of the REDUCE-IT® cardiovascular outcomes study European Commission decision on the Marketing Authorisation Application expected in April 2021 DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced that in response to Amarin’s […]
The Rhythm Express RX-1 mini sets a new standard for patient comfort and simplicity ST. PAUL, Minn.–(BUSINESS WIRE)–VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, is proud to announce launch of the RX-1 mini. The mini is the smallest one-piece mobile cardiac telemetry device on the […]
NYON, Switzerland, Jan. 28, 2021 /PRNewswire/ — 12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, for the treatment of long tibial occlusive […]
Filing includes one year-follow up data from the STTAR Clinical Study. NEWTOWN, Pa., Jan. 28, 2021 /PRNewswire/ — Micro Interventional Devices, Inc.™ (MID) announced today that it has submitted the required technical documentation for CE Mark approval for its MIA-T™ Percutaneous Tricuspid Annuloplasty System for tricuspid valve repair to its Notified Body. The receipt of a […]
WINNIPEG, MB, Jan. 27, 2021 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the early completion of iSPASM, a randomized, double-blind, single-center, Phase 1/2a trial aimed at assessing the safety of long-term (7-day) use of AGGRASTAT® (tirofiban hydrochloride) injection (an intravenous GP IIb/IIIa […]
– MedLumics is developing a unique real-time, optically-guided ablation catheter to improve treatment of Atrial Fibrillation by RadioFrequency Ablation and Pulsed Field Ablation – Presentation on Direct Lesion Assessment using Photonics during AF Ablation MADRID, Jan. 28, 2021 /PRNewswire/ — MedLumics, a privately held medical technology company developing AblaView®, an optically-guided RadioFrequency […]
Three studies show that the FLEX Vessel Prep System safely and effectively modifies obstructive plaque to facilitate definitive therapies MINNEAPOLIS , Jan. 28, 2021 / PRNewswire / – VentureMed Group, Inc. (VentureMed), a privately held innovative medical technology company, today announced that the results of three studies examining the use of the FLEX Vessel Prep […]
